Big Gain For Sierra Oncology, Inc.
Fri, Dec 06, 2019 at 05:30 PM
Sierra Oncology, Inc. (SRRA:NASDAQ) rocketted at $0.49, representing a gain of 26.6%. The stock got featured on our News Catalysts scanner on Tue 26 Nov 19 at 07:37 AM in the 'PUBLIC OFFERING' category. From Thu 14 Nov 19, the stock recorded 50.00% Up Days and 26.67% Green Days
About Sierra Oncology, Inc. (SRRA:NASDAQ)
Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.
Top 10 Gainers:
- The McClatchy Company (MNI:NASDAQ), 37.36%
- Genesco Inc. (GCO:NYSE), 32.27%
- Big Lots, Inc. (BIG:NYSE), 31.58%
- KLX Energy Services Holdings, Inc. (KLXE:NASDAQ), 30.73%
- Wellesley Bancorp, Inc. (WEBK:NASDAQ), 30.34%
- Cancer Genetics, Inc. (CGIX:NASDAQ), 26.86%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 26.6%
- Atlantic American Corporation (AAME:NASDAQ), 26.45%
- DermTech, Inc. (DMTK:NASDAQ), 26.06%
- SAExploration Holdings, Inc. (SAEX:NASDAQ), 25%